| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |